|
Department of Internal Medicine
Division
of Infectious Diseases
Articles,
Patents and Intellectual Property
Vakulenko
SB, Taibi-Tronche P, Toth M, Massova I, Lerner SA, Mobashery S.
Effects on substrate profile by mutational substitutions at positions 164
and 179 of the class A TEMpUC19 (-lactamase
from Escherichia coli. J Biol Chem,
274;33:23052-23060, 1999.
Abraham
OC, Chandrasekar PH. Emergence of
antimicrobial-resistant infections in cancer patients.
Indian J Med Microbiol (In press)
Abraham
OC, Alangaden GJ, Chandrasekar PH. Cervical adnitis due to Mycobacterium
fortuitum in a patient with AIDS. Infect
Dis Clin Pract. (In press)
Abraham,
O C, Manavathu EK, Cutright JL, Chandrasekar PH. In vitro susceptibilities of Aspergillus species to
voriconazole, itraconazole and amphotericin B. Diag Microbiol Infect Dis, 33:
7-11, 1999.
Aeschlimann
J, Dresser L, Kaatz G, Rybak M: Effects of NorA inhibitors on in vitro
antibacterial activities and postantibiotic effects of levofloxacin,
ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus
aureus. Antimicrob. Ag Chemother. 43:335-340, 1999.
Aeschlimann
J, Kaatz G, Rybak M: The effects of NorA inhibition on the activities of
levofloxacin, ciprofloxacin and norfloxacin against two genetically related
strains of Staphylococcus aureus in an in-vitro infection model. J. Antimicrob.
Chemother. 44:343-349, 1999.
AIDS
(CPCRA). Evolution of vaginal
Candida species recovered from HIV-infected women receiving fluconazole
prophylaxis: The emergence of Candida
glabrata? Clin Infect Dis
28:1025-31, 1999.
Bajjoka
IE, Bailey EM, Vazquez JA, Abouljoud MS.
Combination antifungal therapy for invasive aspergillosis infection in
liver transplant recipients: report of two patients. Pharmacother 19:118-123, 1999.
Ben-Josef
AV, Manavathu EK, Platt D, Sobel JD. Involvement
of calcium inhibitable binding to the cell wall in the fungicidal activity of
CAN-296. J Antimicrob Chemo
44:217-222, 1999.
Ben-Josef,
AM, Manavathu EK, Platt D, Sobel JD. Proton
translocating ATPase-mediated fungicidal activity of a novel complex
carbohydrate: CAN-296. Intl J Antimicrob Ag, 13:287-295, 1999.
Birk
TJ, McGrady A, MacArthur RD, Khuder S. The
effects of massage therapy alone and in combination with other complementary
therapies on immune function and quality of life in HIV.
J Alternative and Complementary Medicine, (In press)
Brown
PD. Antibiotic Selection for UTI:
new microbiologic considerations. Curr
Infect Dis Reports 1:384-388, 1999.
Chandrasekar
PH, Alangaden G, Manavathu E. Aspergillus
Ð A rising problem in tertiary care hospitals? Clin Infect Dis (In press)
Chandrasekar
PH, Cutright JL, Manavathu EK. Efficacy
of voriconazole against invasive pulmonary aspergillosis. J Antimicrob Chemother
(In press).
Chandrasekar
PH. Management of fever in
neutropenia cancer patients: Review. Hospital Physician (In press)
Chandrasekar,
PH, Cutright JL, Manavathu EK. Efficacy
of voriconazole vs. amphotericin B in the guinea pig model of pulmonary
aspergillosis. J Antimicrob Chemother 44 (Suppl. A) 53, 1999.
Chandrasekar,
PH, Manavathu EK,. Alangaden GJ. Aspergillus - a rising problem in tertiary care
hospitals? Clin Infect Dis, (In
press).
Chow
JW, Yu VL. Combination antibiotic
therapy vs. monotherapy for gram-negative bacteremia: a commentary. Internat J
Antimicrob Agents 11:7-12, 1999.
Cinti
SK, Kaul DR, Sax PR, Crane LR, Kazanjian PH: Recurrence of mycobacterium avium
infection in patients receiving highly active antiretroviral therapy and
antimycobacterial Agents. Clin Infect Dis (In press)
Cu-Uvin
S, Hogan JW, Warren D, Klein RS, Peipert J, Schuman P, Holmberg, Anderson J,
Schoenbaum E, Vlahov D, Mayer KH. Prevalence
of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive
and high-risk HIV-seronegative women. Clin
Infect Dis 29(5)1145-1150, 1999.
Dworkin
MS, Sullivan PS, Buskin SE, Harrington RD, Olliffe J, MacArthur RD, Lopez DE.
Bordetella bronchiseptica infection in Human Immunodeficiency Virus-infected
patients. Clin Infect Dis 28:1095-9, 1999.
Ebright
J, Chandrasekar PH, Marks S., Fairfax MR, Aneziokoro A, McGinnis MR.
Invasive sinusitis and cerebritis due to curvularia clavata in an
immunocompetent adult. Clin Infect Dis 28:687-9, 1999.
Ebright
J, Moldenhauer J, Gonik B. Nonsurgical
management of post cesarean endomyometritis with myometrial gas formation.
Infect Dis Obstet Gynecol (In press)
Ebright
JR, Chandrasekar PH, Marks S, Fairfax MR, Aneziokoro A, McGinnis MR. Invasive
sinusitis and cerebritis due to Curvularia clavata in an immunocompetent adult.
Clin Infect Dis 28:687-689, 1999.
El-Sadr
WM, Burman WJ, Bjorling Grant L, Matts JP, Crane L, Zeh D, Gallagher B,
Mannheimer S, Martinez A, Hafner R, Gordin F:
Prophylaxis for mycobacterium avium complex disease can be safely
deferred or discontinued among HIV-infected patients who experience CD4 cell
rebound with antiretroviral therapy: results of a randomized placebo-controlled
multicenter trial: CR-MAC Study (CPCRA 048).
N Engl J Med, (In press).
El-Sadr
WM, Luskin-Hawk R, McCurik TM, Walker J, Abrams D, St Johns, Sherer R, Crane LR,
Labrioloa A: a randomized trial of
daily and thrice weekly trimethoprim sulfamethoxazole for the prevention of
Pneumocystis carinii pneumonia in HIV-Infected individuals.
Clin Infect Dis, 29:775-783, 1999.
Espinel-Ingroff
A, Vazquez JA, Boikov D, Pfaller MA. Evaluation
of DNA-based typing procedures for strain categorization of Candida spp.
Diagn Microbiol Infect Dis 33(4):231-9, 1999.
Fidel PL Jr, Vazquez JA, Sobel JD. Candida
glabrata: review of epidemiology,
pathogenesis and clinical disease. Clinic
Micro Review 12:80-96, 1999.
Fidel
PL, Vazquez JA, Sobel JD. Candida
glabrata: review of epidemiology, pathogenesis and clinical disease with
comparison to C. albicans. Clin
Microbiol Rev 12:80-96, 1999.
Flanigan
TP, Hogan JW, Smith D, Schoenbaum E, Vlahov D, Schuman, Mayer K.
Self-reported bacterial infections among women with or at risk for human
immunodeficiency virus infection. Clin
Infect Dis 29:608-12, 1999.
Foxman
B, Barlow R, dÕArcy H, Gillespie B, Sobel JD.
Candida vaginitis: self-reported
incidence and associated costs. Sex
Trans Dis (In press).
Foxman
B, Barlow R, dÕArcy H, Gillespie B, Sobel JD.
Urinary tract infection: self-reported
incidence and associated costs. Ann Epidemiol (In press).
Foxman
B, Gillispie B, Koopman J, Zhang L, Palin K, Tallman P, Marsh JV, Spear S, Sobel
JD, Marty MJ, Marrs CF. Risk
factors for second urinary tract infection among college women.
Am J Empidemiol (In press).
Graybill
JR, Sobel JD, Saag M, VanderHorst C, Powderly W, Cloud G, Riser L, Hamill R,
Dismukes W. Diagnosis and
management of increased intracranial pressure in patients with AIDS and
cryptococcal meningitis. Clin
Infect Dis 30:47-54, 2000.
Harlow
S, Schuman P, Cohen M, Ohmit SE, Cu Uvin S, Lin X, Anastos K, Burns D, Young M,
Mucerspach L, Rompalo A, Minkoff H, Warren D, Greenblatt R. The effect of HIV
infection on menstrual cycle length. JAIDS (In press).
Hidalgo
JA, Alangaden GJ, Akins RA, Abrams GW, Eliott D, Puklin J, Vazquez JA.
Diagnosis of fungal endophthalmitis by detection of Candida albicans DNA
in intraocular fluid using a species-specific PCR.
J Infect Dis (In press).
Hidalgo
JA, Logani S, MacArthur RD. Pulmonary
mucormycosis in an AIDS patient: case report and review of the literature.
Infect Dis Clin Prac, (In press)
Hidalgo
JA, MacArthur RD, Crane LR. An
overview of HIV infection and AIDS. Sem
Cardiovasc Surg, (In press)
Hillier
SL, Schwebke JR, Sobel JD, McGregor JA, Sweet RL. Clinical evaluation of the FemExam Testcard for detection of
elevated pH and trimethylamine. Sex
Trans Dis (In press).
Jandourek
A, Brown P, Vazquez JA. Community
acquired fungemia due to a multi-azole resistant Candida tropicalis.
Clin Infect Dis 29:1583-1584, 1999.
Kaatz
G, Seo S, Foster T: Introduction of a norA promoter-region mutation into the
chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus
using plasmid integration. Antimicrob. Agents Chemother. 43:2222-2224, 1999.
Kak
V, Levine DP: Community-acquired methicillin-resistant staphylococcus aureus
infections Ð where do we go from here? Clin Infect Dis 29:801-802, 1999.
Kak
V, MacArthur RD, Crane LR. Treatment
of HIV disease in the new millennium. Sem Cardiovasc Surg, (In press)
Kanno
MB, Brown PD. Community-acquired
pneumonia: an overview. Curr Infect
Dis Reports 1:49-56, 1999.
Kaufmann
C, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, Sugar AM, Sharkey
PK, Wise GJ, Mangi R, Mosher A, Lee JY, Dismukes WE, and the NIAID Mycoses Study
Group A prospective multicenter
surveillance study of funguria in hospitalized patients.
Clin Infect Dis 30:14-18, 2000.
Klein
R, Arnstein J, Sobel JD. Oropharyngeal
Candida colonization and human immunodeficiency virus type-1 infection.
J Infect Dis (In press).
Klein
R, Mayer K, Schuman P, Vlahov D, Holmberg S. The effect of immunodeficiency on
cutaneous delayed-type hypersensitivity testing in HIV-infected women without
anergy: implications for tuberculin testing. Int J Tuberc Lung Dis 3(8):681-699,
1999.
Klein
RS, Sobel JD, Flanigan T, Smith D, Margolick JB and the HIV Epidemiology
Research Study Group. Stability of
cutaneous anergy in women with or at risk for HIV infection.
J Acquired Imm Def Synd and Human Retrovir 20:238-244, 1999.
Liu
C, Abate B, Reyes M, Gonik B. Single
daily dosing of gentamicin: pharmacokinetic
comparison of two dosing methodologies for postpartum endometritis.
Infect Dis Obstet Gyecol 7:133-137, 1999.
MacArthur
RD, Crane LR, Cohn JA. Antiretroviral
Recommendations, Detroit Medical Center. Updated annually; adopted by the State
of Michigan AIDS Drug Assistance Program, and distributed widely to health care
professionals (multistate area).
MacArthur
RD, Lederman MM, Benson CA, Chernoff MC, MacGregor RR, Spritzler J, Mahon LF,
Yen-Lieberman B, Purvis S. Effects
of treatment for MAC infection on cytokine expression in HIV-infected persons:
results of AIDS Clinical Trials Group protocol 853. J Infect Dis (In press).
MacArthur
RD. Sequencing antiretrovirals.
The AIDS Reader, (In press)
Manavathu
EK, Ben-Josef AV, Sobel JD. Proton
translocating ATPase mediated fungicidal activity of a novel complex
carbohydrate: CAN-296.
Internat J Antimicrob Ag (In press).
Manavathu
EK, Kallakuri S, Arganoza MT, Vazquez JA. Amino
acid variations of cytochrome P450-dependent lanosterol 14a-demethylase from
fluconazole-resistant clinical isolates of Candida albicans. Iberoamericana
Micologia, 16:198-203, 1999.
Manavathu
EK, Nune U, Kanuri K, Abraham OC, Cutright JL, Chandrasekar PH.
Effect of test medium on the in-vitro susceptibility of Aspergillus
fumigatus to antifungal agents. Canadian J Microbiol (In press).
Manavathu
EK, Vazquez JA, Chandrasekar PH. Reduced
susceptibility of aspergillus fumigatus to Itraconazole due to decreased
intracellular accumulation of the antifungal agent.
Internat J Antimicrob Agents 12:213-219, 1999.
Manavathu,
EK, Cutright JL, Chandrasekar PH. A
comparative study of the susceptibility of germinated and ungerminated conidia
of Aspergillus fumigatus to various antifungal agents. J Clin Microbiol, 37:
858-861, 1999.
Manavathu,
EK, Dimmock JR, Vashishtha SC, Cutright JL, Chandrasekar PH. Proton pumping
ATPase directed antifungal activity of a novel conjugated styryl ketone.
Antimcrob Ag Chemother, 43:2950-2959, 1999.
McNeil
SA, Clark NM, Chandrasekar PH, Kauffman CA.
Successful treatment of vancomycin-resistant Enterococci faecium
bacteremia with linezolid after failure of synercid Quinupristin/Dalfopristin)
Treatment. Clin Infect Dis (In
press)
Moore
J, Schuman P, Schoenbaum E, Boland B, Solomon L, Smith D.
Severe adverse life events and depressive symptoms among women with, or
at risk for, HIV infections in four cities in the United States of America.
AIDS 13:2459-2468, 1999.
O’Neil
WM, Drobitch RK, MacArthur RD, Farrough MJ, Doll MA, Fretland AJ, Hein DW, Crane
LR, Svensson CK: Acetylator
phenotype and genotype in patients infected with HIV: Discordance between
methods for phenotype determination and genotype. Pharmacogenetics, (In press).
Phelps
RM, Smith DK, Gardner L, Carpenter C, Klein RS, Vlahov D, Schuman P, Holmberg S.
Incidence of cancer in women with or at risk for HIV infection. Arch Int Med (In
press).
Prasad
AS, Beck FWJ, Kaplan J, Chandrasekar PH, Ortega J, Fitzgerald JT, Swerdlow P.
Effect of zinc supplementation on incidence of infections and hospital
admissions in sickle cell disease (SCD). Am
J Hematol 61:194-202, 1999.
Reilly
TP, MacArthur RD, Farrough MJ, Crane LR, Woster PM, Svensson CK: Is
hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions
to sulfamethoxazole in HIV-infected individuals?
J Pharmacol Exp Ther,
291:1356-1364, 1999.
Rex
JH, Sobel JD. Preventing
intra-abdominal candidiasis in surgical patients.
Critical Care Medicine. 27:1033-1034, 1999.
Rex
JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE: Treatment
guidelines for candidiasis. Clin
Infect Dis (In press)
Rompalo
A, Astemborski J, Schoenbaum E, Schuman P, Carpenter C, Holmberg S, Warren D,
Farzadegan H, Vlahov D, Smith D. Comparison
of clinical manifestations of HIV infection among women by risk group, CD4+ cell
count and HIV-1 plasma viral load. J AIDS Apr.15;20(5):448-54.
Saag
MS, Cloud GA, Graybill JR, Sobel JD, et al.
A comparison of itraconazole versus fluconazole as maintenance therapy
for AIDS-associated cryptococcal meningitis.
Clin Infect Dis 28:291-6, 1999.
Saag
MS, Graybill JR, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD,
Dismukes WE: Guidelines for the management of cryptococcal disease.
Clin Infect Dis (In press)
Sankar
A, Luborsky M, Schuman P, Roberts G. Adherence
to anti-retroviral therapy among African American women: resources and
challenges. AIDS & Behavior, (In press).
Sarma
AV, Foxman B, Bagirli B, Haefner H, Sobel JD.
Epidemiology of vulvar vestibulitis syndrome: an exploratory case control study. Sex Trans Infect 75:320-326, 1999.
Schoenbaum
EE, Chang CJ, Moore J, Mayer K, Schuman P, Rompalo A, Warren D.
Patterns in condom use among women participating in the HIV epidemiology
research study. AIDS & Behavior (In press).
Schuman
P, Ohmit SE, Moore J, Schoenbaum E, Boland R, Rompalo A,
Solomon L for the HIV Epidemiology Research Study (HERS) Group.
Utilization of mental health services by women living with or at risk for
HIV infection. AIDS & Behavior (In press).
Silverman
J, Vazquez JA, Sobel JD, Zervos MJ. Comparative in vitro activity of antiseptics and disinfectants
versus clinical isolates of Candida species.
Infect Control & Hosp Epidemiol 20:676-684, 1999.
Sobel
JD, Kauffman CA, McKinsey D, Zervos D, Vazquez JA, Panzer H, Dismukes W.
Candiduria in a randomized double blind study of treatment with
fluconazole and placebo. Clin Infect Dis 30:19-24, 2000
Sobel
JD, McKinsey D, Kauffman C, Zervos MJ, Vazquez JA, Lee J and the Mycosis Study
Group, NIAID. Asymptomatic
candiduria - a randomized, double blind study of treatment with fluconazole and
placebo. Ann Intern Med (In press).
Sobel
JD, Nagappan, V, Nyirjesy P. Metronidazole-resistant
vaginal trichomoniasis Ð an emerging problem.
N Engl J Med 341:292-293.Sobel JD, Vazquez JA.
Fungal infections of the urinary tract.
World J Urol (In press).
Sobel
JD, Vazquez JA: Urinary tract
infections due to fungi. World J of
Urology 17:410-4, 1999.
Sobel
JD. Mass or syndromic treatment of
sexually transmitted diseases. Curr
Infect Dis Reports 1:365-366, 1999.
Sobel
JD. Protective role of vaginal
flora. Curr Infect Dis Reports
1:379-383, 1999.
Sobel
JD. Treatment of fungal disease in
pregnancy. ADIS Publication, (In
press).
Sobel
JD. Vulvovaginitis in healthy
women. Comprehensive Ther
25:335-346, 1999.
Sobel
JD: Asymptomatic candiduria, review
of treatment. Internat J
Antimicrobial Ag 11:285-288, 1999.
Sobel
JD: Bacterial vaginosis.
Ann Rev Med 57:29-47, 2000.
Sobel
JD: Diagnostic considerations in
microscopy-negative Candida vaginitis. Ital
J Gynecol Obstet 2:73-78, 1999.
Sobel
JD: Diagnostic strategems in the
management of patients with acute and chronic vaginitis.
Contemporary Obstet Gynecol (Canada) (In press).
Sobel
JD: Limitations of antifungal
agents in the treatment of Candida vaginitis:
future challenges. Drug resistance Updates 2:148-153, 1999.
Vazquez
JA, Sobel J, Peng G, Schuman P, Steele-Moore L, Holloway W and Neaton J for the
Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA).
Evolution of vaginal candida species recovered from HIV-infected women
receiving flucanazole prophylaxis: The emergence of candida glabrata?
Clin Infect Dis 28:(3)1025-1031, 1999.
Vazquez
JA. Options for the
management of mucosal candidiasis in patients with AIDS and HIV infection.
Pharmacother 19:76-87, 1999.
Vazquez
JA. Strategies in the management of
vulvovaginal candidiasis. Excepta
medica Asia, Ltd., Elsevier Science, Amsterdam, (In press).
Vazquez,
JA. Epidemiology of Candida
vulvovaginitis: emergent species and antifungal susceptibility. Rev.
Iberoamericana de Micología (In press).
Villanueva
AV, Sahouri MJ, Ormerod LD, Puklin JE, Reyes MP. Posterior uveitis in patients with positive serology for
syphilis. Clin Infect Dis (In
press).
Villanueva,
A., Chandrasekar, P.H. Parvovirus
B19 infection presenting as aplasia and pain crisis in a patient with sickle
cell disease. Hospital Physician
June, pp. 64-71, 1999.
Weingarten
CM, Rybak MJ, Brown WJ, Jahns BE, Stevenson JG, Levine DP.
An evaluation of acinetobacter baumannii infections and antimicrobial
treatment patterns in an urban teaching hospital.
Pharmacother 19:1080-1085, 1999.
Yoon
SA, Vazquez JA, Steffan PE, Sobel JD, Akins RA. High frequency, in vitro reversible switching of Candida
lusitaniae clinical isolates from amphotericin B-susceptible to resistance.
Antimicrob Ag Chemother 43:836-845, 1999.
You
I, Kariyama R, Zervos MJ, Kumon H, Chow JW.
In-vitro activity of arbekacin alone and in combination with vancomycin
against gentamicin- and methicillin-resistant staphylococcus aureus. Diagn
Microb Infect Dis (In press)
Zierler
S, Mayer K, Moore J, Stein M, Schoenbaum E, Schuman P, Rompalo A.
Sexual practices in a cohort of HIV seropositive and HIV seronegative US
women. JAMWA. Spring; 54(2):79-83, 1999.
Books,
Chapters and Reviews
Alangaden
GJ. Leptospirosis. In: KellyÕs Textbook of Internal Medicine (Fourth edition).
Lippincott Williams & Wilkins, New York. 299:199-201 (In press).
Chow
JW, Shlaes DM. Enterococcus species. In: Yu VL, Merigan TC, Jr., Barriere SL,
eds. Antimicrobial therapy and vaccines. Baltimore, MD: Williams and Wilkins;
1999.
Fidel
PL Jr, Sobel JD. Murine models of
Candida vaginal infection. In:
Handbook of animal models of infection. Zak
O, Sande M (Editors), Academic Press, Guersney UK, Chapter 3, (In press).
Lerner
SA, Brown PD. Antimicrobial therapy
and vaccines. N Engl J Med
341:771-72, 1999.
Lundstrom
TS, Crane L. Human immunodeficiency
virus and acquired immunodeficiency syndrome.
In: APIC Infection Control
and Applied Epidemiology: Principles
and Practice, R Olmstead (Editor), Mosby Year Book, Inc, St. Louis, Missouri (In
press).
Lundstrom
TS, Sobel JD. Antibiotics for gram
positive bacterial infections: vancomycin,
teicoplanin, quinupristin/dalfopristin and linezolid.
In: Infect Dis Clin N Am, D.
Kaye (Editor), W.B Saunders Co, Philadelphia, PA.
(In press)
Lundstrom
TS, Sobel JD: Fungal infections.
In: APIC Infection Control
and Applied Epidemiology: Principles
and Practice, R Olmstead (Editor), Mosby Year Book Publishers, St. Louis,
Missouri (In press).
MacArthur
RD, Abbas M. Sepsis and septic shock. In:
Schlossberg D, ed. Current Therapy of Infectious Disease.
Philadelphia: Mosby. (In press).
MacArthur
RD. Infections: etiology,
prevention, and treatment. In:
Skeel RT, ed. Handbook of Cancer Chemotherapy (5th ed).
Philadelphia: Lippincott Williams & Wilkins. 574-97, 1999.
Sobel
JD, Kaye D. Urinary Tract
Infections. In:
Principles and practice of Infectious Diseases.
Mandell G, Bennett J, Dolin R (Editors), Churchill Livingston,
Philadelphia, PA, 5th Edition, Vol 1, Chapt 62, pp 773-805, 2000.
Sobel
JD, Vazquez J: Fungal infections of
the urinary tract. In:
Comprehensive Clinical Nephrology, RJ Johnson, J Feehally (Editors), Mosby
International, Chapt 58, Section 10, pp 58.1-58.6, 1999.
Sobel
JD, Vazquez JA. Fungal infections
in the critically ill. In:
Infections in the ICU. HKF van
Saene (Ed.), Oxford University Press, Liverpool, UK.
(In press).
Sobel
JD. Biotherapeutic agents as
therapy for vaginitis. In:
Probiotic therapy, GW Elmer, LV McFarland, CM Surawicz (Editors), Humana
Press, Inc, Totowa, NJ, 221-244, 1999.
Sobel
JD. Mucocutaneous candidiasis.
In: Fungal Infections, R Diamond (Editor), Atlas of Infectious Diseases
(In press).
Sobel
JD: Candida vaginitis.
In: Infectious Diseases in Obstetrics and Gynecology, S Faro, M Maartens,
D Soper (Editors), WB Saunders, (In press).
Sobel
JD: Candida vaginitis.
In: Vulvovaginal disease, Ledger W and Witkin J (Editors), W.B. Saunders
Co, New York, NY, (In press).
Sobel
JD: Candiduria.
In: Current Therapy of
Infectious Diseases, Schlossberg D (Editor), Mosby Year Book, Philadelphia, PA.
(In press).
Sobel
JD: Cervicitis.
In: America College of
Physicians (In press)
Sobel
JD: Fungal infections of the
genitourinary tract. In: Clinical
Mycology, E Anaissie, M McGinnis, M. Pfaller (Editors), WB Saunders, (In press).
Sobel
JD: Genital candidosis.
In: International Standard
Book for Infectious Diseases in Obstetrics, Gynecology, Dermatology, Urology,
and Clinical Immunology, Weissenbacher ER (Editor), Medifact Publishing House,
Munich, Germany (In press)
Sobel
JD: Urinary tract infections:
Uncomplicated, complicated, and nosocomial.
In: Curr Prac Med. FT Fitzgerald (Editor), Vol 2, Number 4, Chapter 164:555-562,
1999.
Sobel
JD: Vaginitis.
In: American College of
Physicians (In press)
Sobel
JD: Vulvitis, vaginitis and
cervicitis. In: Infectious Disease,
D Armstrong, Cohen J (Editors), Mosby, London, United Kingdom (In press).
Sobel
JD: Vulvovaginal candidosis.
In: Medicine, UK, (In press).
Vazquez
JA. Applications of PCR in
mycology. (Book Review).
Bridge, PD, Arora DK, Reddy CA, and Elander RP (Eds) (CAB International).
Mycopathologia.(In press).
Vazquez
JA. Zygomycosis (mucormycosis,
phycomycosis). Medicine, OB-GYN,
Psychiatry, and Surgery.
eMedicine.com (In press).
Yoon
SA, Boikov D, Vazquez JA, Akins RA. Identification
and characterization of atypical Candida parapsilosis isolates. In: Programs and
Abstracts of the 5th Candida and Candidiasis Meeting, Charleston, South
Carolina, March 1-4, 1999.
Abstracts,
Letters to the Editor and Articles in Non-Refereed Journals
Abraham
OC, Klein J, Chalasani G, Cassells L, Dansey R, Abella S, Karanes C, Peters W,
Baynes R, Chandrasekar PH. Infectious
complications in women undergoing autologous peripheral blood progenitor cell
transplantation (PBPCT) for breast cancer.
In: Programs and Abstracts of 37th Annual Meeting of the Infectious
Diseases Society of America, Philadelphia, PA, November 1999.
Berman
W, Crane LR: Low Rates of All Opportunistic Infections Among
Patients with Advanced HIV Disease Responding to Antiretroviral
Therapy...the CPCRA 048 Cohort. Abst
241 7th Conference on Retroviruses and Opportunistic Infections.
2000 San Francisco
Brown
PD, Jandourek A, Vazquez JA. Communityacquired
fungemia due to a multi-azole resistant Candida tropicalis. Infectious Diseases
Society of America 37th Annual Meeting. Philadelphia, Pennsylvania 1999.
Cheng
P, Doyle M, Panthangi V, Rahman A, MacArthur RD, Kosmyna JM, Crane LR, Podzorski
R, Draghici S, Kovari LC: Mechanisms of HIV-1 Protease Drug Resistance.
Abst 448 Infectious Diseases Society of American Nov 18-21, 1999.
Cinti
SK, Gallant JE, Sax PE, Crane L, Armstrong W, Kaul D, Kazanjian P: Breakthrough
of Mycobacterium avium Infection in Patients Responding to HAART and Receiving
Antimycobacterial Treatment. Abst
410 Infectious Diseases Society of American Nov 18-21, 1999
Douglas
MA, Levine DP. Hallucination in an
elderly patient taking recommended doses of cyclobenzaprine.
Arch Int Med (In press).
Eliott
D, Vazquez JA, Abrams G, Akins R, Puklin J.
New diagnostic techniques for fungal endophthalmitis.
Vitreoretinal Meeting, Rome, Italy, September 21-25, 1999.
El-Sadr
W, Burman W, Grant L, Matts JP, Zeh D, Crane LR, Gallagher B, Gordin F:
Prophylaxis for Mycobacterium avium Complex can be deferred among patients with
a past CD4 Count <50 Who Responded to Antiretroviral Therapy Abst 247. 7th
Conference on Retroviruses and Opportunistic Infections. 2000 San Francisco.
Espinel-Ingroff
A, Perfect J, Pickward W, Steele-Moore L, Akins R, and Vazquez JA.
DNA subtyping and azole MICs for Candida glabrata during voriconazole
therapy. In: Programs and Abstracts
of the 5th Candida and Candidiasis Meeting, Charleston, South Carolina, March
1-4, 1999.
Gardner
L, Smith D, Stone V, Howard A, Schuman P, Rompalo A, Hamburger M, Holmberg, S.
Adherence to antiretroviral medications in the HERS study.
39th Interscience Conference on Antimicrobial Agents and Chemotherapy.
Abstract No. 592. September 26-29, 1999.
Hedderwick
S, Lyons M, Liu M, Vazquez J, Kauffman C. Epidemiology
of yeast colonization in the intensive care unit.
9th European Congress of Clinical Microbiology and Infectious Diseases
5(Suppl 3):281, 1999, March 21-24, 1999.
Hershberger
E, Coyle E, Kaatz G, Zervos M, Rybak M. In vitro fibrin-clot infection model
versus rabbit model of bacterial endocarditis. ICAAC 39:A23, 1999.
Hidalgo
JA, Akins RA, Brown W, Vazquez JA. Invasive
Candida dubliniensis infection in a non-HIV-positive patient.
Verification with RAPD and a species-specific probe.
In: Programs and Abstracts of the 37th Annual Meeting of the Infectious
Diseases Society of America. Philadelphia,
Pennsylvania, November 18-21, 1999.
Hidalgo
JA, Alangaden GJ, Akins RA, Abrams GW, Eliott D, Puklin J, Chandrasekar PH,
Vazquez JA. Diagnosis of fungal endophthalmitis by detection of Candida albicans
DNA in vitreous specimens using a species-specific PCR. In: Programs and
Abstracts of 37th Annual Meeting of the Infectious Diseases Society of America,
Philadelphia, PA, November 1999.
Hidalgo
JA, Vazquez JA. Candida
dubliniensis in an immunocompetent patient presenting with an intra-abdominal
abscess. American College of
Physicians Fall Scientific Meeting, Traverse City, Michigan, September 24-26,
1999.
Issa
N, Kak V, Brown P. Post endoscopic
retrograde cholangiopancreatography cholangitis due to Streptococcus pneumoniae:
an unusual case. American College of Physicians Associates Meeting. Detroit,
Michigan 1999.
Kaatz
G, Seo S, OÕBrien L, Hartford O, Foster T:
Comparison of sequence disruption versus deletion of norA in
Staphylococcus aureus 8325-4. ICAAC 39:C810, 1999.
Kaatz
G, Seo S: A mutation in a perfect
inverted repeat in the promoter of norA affects gene expression. ICAAC 39:C672,
1999.
Kak
V, You I, Zervos MJ, Chow JW. In-vitro
synergistic activity of ampicillin and arbekacin against vancomycin-resistant
enterococcal isolates with high level aminoglycoside resistance due to APH(2Ó).
In: Program & Abstracts 39th Interscience Conference on Antimicrobial Agents
& Chemotherapy, 1999.
Kariyama
R, Kumon H, Zervos MJ, Chow JW. Combinations
of ampicillin, fosfomycin, and arbekacin against (-lactam, glycopeptide-, and
high-level gentamicin-resistant Enterococcus faecium. Abstr. #P523. 21st
International Congress of Chemotherapy, 1999.
Kazanjian
P, Armstrong W, Hossler PA,
Richardson J, Crane LR, Katz J, Burman R, Meshnick S: Pneumocystis carinii
mutations are associated with duration of sulfa prophylaxis and with sulfa
treatment failure and in AIDS Patients. Abst 229. 7th Conference on Retroviruses
and Opportunistic Infections. 2000 San Francisco.
Levine
DP and the Clinafloxacin Study Group. Clinafloxacin monotherapy for prosthetic
valve endocarditis. Fifth International Symposium on Modern Concepts in
Endocarditis and Cardiovascular Infections. Amsterdam, The Netherlands. July
1-3, 1999.
MacArthur
RD, Kosmyna JM, Crane LR, Kovari L, Podzorski R. Sequencing of non-nucleoside reverse transcriptase inhibitors
based on specific mutational patterns fails to lower plasma HIV-RNA levels in
persons extensively pre-treated with antiretrovirals who are failing
virologically on nevirapine-containing antiretroviral regimens.
Abstracts of the Seventh European Conference on Clinical Aspects and
Treatment of HIV-Infection, 208, 1999.
MacArthur
RD, Kosmyna JM, Crane LR, Kovari L. The
presence of absence of zidovudine in a nevirapine-containing antiretroviral
regimen determines which of two nevirapine-limiting mutations occurs on
virologic failure. Abstracts of the
39th ICAAC, 1171, 1999.
Manavathu,
EK, Abraham OC, Cutright JL, Chandrasekar PH.
Isolation and in vitro susceptibility to amphotericin B (AMB),
itraconazole (ITZ) and SCH56592 (SCH) of voriconazole (VCZ)-resistant laboratory
isolates of Aspergillus fumigatus. In: Abstracts of the 99th General Meeting of
the American Society for Microbiology, Abstract A69, 1999.
Manavathu,
EK, Cutright JL, Chandrasekar PH. Species diversity and in vitro antifungal
susceptibility of clinical isolates of Aspergillus obtained in a Medical Center
from January 1994 to December 1998. In Abstracts of the 39th Interscience
Conference on Antimicrobial Agents and Chemotherapy, Abstract 1512. p. 570,
1999.
Manavathu,
EK, Dimmock JR, Chandrasekar PH. H+-ATPase-dependent
activity of a novel conjugated styryl ketone against Cryptococcus neoformans. In
Abstracts of the 39th Interscience Conference on Antimicrobial Agents and
Chemotherapy, Abstract 1942. p. 345, 1999.
Manavathu,
EK, Loebenberg D, Cutright JL, Chandrasekar PH. A comparative study of the in vitro susceptibility of
Aspergillus species to SCH56592 (SCH), amphotericin B (AMB), itraconazole (ITZ)
and voriconazole (VCZ). In: Abstracts of the 99th General Meeting of the
American Society for Microbiology, Abstract A121, 1999.
McKinnon
P, Nagappan V, Levine DP, Rybak M. Evaluation
of pharmacodynamics and clinical and microbiologic outcomes of infective
endocarditis in patients treated with once daily aminoglycosides.
Fifth International Symposium on Modern Concepts in Endocarditis and
Cardiovascular Infections. Amsterdam, the Netherlands.
July 1-3, 1999.
McKinnon
P, Nagappan V, Rybak M, Levine DP. Evaluation
of clinical and microbiologic outcomes of infective Endocarditis in patients
treated empirically with vancomycin a beta-lactam or a fluoroquinolone.
Fifth International Symposium on Modern Concepts in Endocarditis and
Cardiovascular Infections. Amsterdam,
The Netherlands. July 1-3, 1999.
Meghashyam
J, Thal L, Donabedian SM, Chow J, Zervos MJ.
Molecular evaluation of vancomycin-resistant Enterococcus faecalis in
Michigan hospitals. Program & Abstracts 39th Interscience Conference on Antimicrobial Agents &
Chemotherapy, 1999.
Odemuviwa
A., Alav F, Ebright JR. Systemic sclerosis and graves disease:
A rare association. Am College of Physicians AssociatesÕ Meeting,
Southfield, MI, May 7, 1999.
Reichelderfer
P, Coombs R, Wright D, Burns D, Cohn J, Kovacs A, and the WHS 001 Study Group.
Variation in genital tract shedding of HIV RNA with the menstrual cycle.
Sixth Conference on Retroviruses and Opportunistic Infections, Chicago
IL, January 31 1998 Ð February 4 1999. Program
and abstracts p110 (abstract# 223), 1999.
Rybak
M, Hershberger E, Thomas A, Seo S, Kaatz G:
Evaluation of newer fluoroquinolones against vancomycin-intermediate
Staphylococci (VISA), coagulase-negative Staphylococcus (VICNS), and MRSA. ICAAC
39:E377, 1999.
Sakka
W, Palakurthi L, Ebright JR. Enterococcal meningitis in an adult.
American College of Physicians AssociatesÕ Meeting, Southfield, MI, May
7, 1999.
Schuman
P, Ohmit SE, Cohen M, Sacks H, Schoenbaum E, Rompalo A, Richardson J, Young M,
DaVenny K. Prescription of
anti-retroviral therapy (ART rx) by health care providers to women: report from
the HIV epidemiology research study (HERS) and womenÕs inter-agency HIV study (WIHS).
The 1999 National Conference of Women and HIV/AIDS. oral presentation.,
Los Angeles, California. Abstract No.157. October 9-12, 1999.
Schuman
P, Ohmit SE, Jones TB, Laken MP. HIV
counseling and testing of pregnant women; An assessment of compliance with
Michigan statutes. The 1999
National Conference on Women and HIV/AIDS.
Round Table Presentation. October
9-12, 1999.
Schuman
P, Ohmit SE, Vazquez J, Klein RS, Mayer K, Rompalo A, Jamieson D, Sobel JD.
Longitudinal assessments of oral and vaginal candida colonization, species and
fluconazole susceptibility in HIV seropositive women. The HER Study. 7th Conference on Retroviruses and
Opportunistic Infections. San
Francisco, California. Abstract No. January 30-February 2, 2000.
Schuman
P, Vazquez J, Klein RS, Mayer K, Rompalo A, Sobel JD. Evolution of fluconazole susceptibility among Candida
isolates. In: Programs and
Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections,
Chicago, Illinois, January 31 Ð February 4, 1999, Abstract #184, 1999.
Thatai
LC, Vazquez JA. Concomitant
aspergilloma and pulmonary blastoma diagnosed intra-operatively: Case report and
review. American College of
Physicians Fall Scientific Meeting, Traverse City, Michigan, September 24-26,
1999.
Thomas
D, Smith D, Flanigan T, Schuman P, Klein RS.
Determinants of hepatitis C viral load in women with or at risk for HIV
infection. 37th Annual Infectious
Diseases Society of America, Philadelphia, Pennsylvania. Abstract No.718.
November 18-21, 1999.
Vakulenko
SB, Lerner SA: Evolution of the
TEM-1 (-lactamse to confer resistance to cefepime (CPM) and/or ceftazidime (TAZ)
following intensive mutagenesis, 99th General Meeting, American Society for
Microbiology, (A-27), 1999.
Vakulenko
SB, Lerner SA: Mutational
alteration in substrate specificity of class C P99 (-lactamase, International
Congress on (-Lactamases, LÕAquila, Italy, 1999.
Vakulenko
SB, Mobashery S, Lerner SA: Extended-spectrum
(E-S), inhibitor-resistant mutants of the TEM-1 (-lactamase, 39th International
Conference on Antimicrobial Agents and Chemotherapy, (2048), 1999.
Vazquez
JA, Yoon SA, Akins RA. Characterization
of in vitro reversible switching of Candida lusitaniae clinical isolates from
amphotericin B-susceptible to resistant phenotypes. In: Programs and Abstracts of the 5th Candida and Candidiasis
Meeting, Charleston, South Carolina, March 1-4, 1999.
Vazquez
JA, Yoon SA, Akins RA. Phenotypic
and molecular characterization of a bid-directional switching mechanism from
amphotericin B-susceptibility to resistant in C. lusitaniae clinical isolates.
In: Programs and Abstracts of the 39th Interscience Conference on
Antimicrobial Agents and Chemotherapy, San Francisco, California, September
26-29, 1999.
Vergis
EN, Shankar V, Gilmore M, Chow JW, Hayden MK, Snydman DR, Zervos MJ, Linden PK,
Wagener MM, Muder RR. Characterization
of virulence factors in patients with Enterococcus faecalis bacteremia. Program
& Abstracts 39th Interscience Conference on Antimicrobial Agents & Chemotherapy, 1999.
Vijayalakshmi
N, McKinnon P, Rybak M, Levine D. Clinical
features, microbiology, complications and treatment outcomes in patients with
infective endocarditis: right-sided vs. left-sided diseases.
Fifth International Symposium on Modern Concepts in Endocarditis and
Cardiovascular Infections. Amsterdam,
The Netherlands. July 1-3, 1999.
Wahiduzzaman
M, Chandrasekar PH, Alangaden GJ. High
frequency of Gram-negative pneumonia in bone marrow transplant/ stem cell
transplant (BMT) recipients with graft-vs-host disease (GVHD) and pulmonary
aspergillosis. In: the Abstracts of the IDSA 37th Annual Meeting, November
18-21, Philadelphia, Pennsylvania. Clin Infect Dis. 29:1014, 1999.
Webber
MP, Schoenbaum EE, Klein RS, and THE HER Study Group:(Schuman, P)
HIV collection from cervicovaginal secretions: comparing lavage and
tampon methods. 37th Annual Infectious Diseases Society of America,
Philadelphia, Pennsylvania. Abstract No. 449. November 18-21, 1999.
Back
to Internal Medicine
|